DCC attends Sydney Innovation Series
The second Innovation Series luncheon for 2009 welcomed two highly respected leaders from within the medical research sector. Each speaker discussed how leading edge medical research discoveries will revolutionise both the healthcare industry and the lives of future generations.
In view of the global success of Australia’s own Cochlear Limited, Assoc Prof. Jim Patrick, Chief Scientist Senior Vice-President, Cochlear Limited, discussed his involvement in cochlear implant research, and how advances in biology and electro-neural interfaces can be applied to improve future implant designs. Drawing upon her experience at the Australian Stem Cell Research Centre and the Institute of Molecular Bioscience, Professor Melissa Little, NHMRC Principal Research Fellow, Institute for Molecular Bioscience, The University of Queensland, discussed ‘New discoveries in Tissue Regeneration’ and how Stem Cell therapy will be the next great advance in medicine.
Davies Collison Cave are delighted to be involved in the Sydney Innovation Series.